Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation

Cardiology in the Young

Volumn 15, Issue 1, 2005, Pages 26-30

  Binotto, Maria A ^a,c   Maeda, Nair Y ^b   Lopes, Antonio A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Pró Sangue Foundation Institute for Investigation in Immunology Iii INCT   (Brazil)

^c NONE   (Brazil)

Author keywords

Cavopulmonary connection; Endothelium; Functionally single ventricle

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; ANTIGEN; VON WILLEBRAND ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FONTAN PROCEDURE; HEART SINGLE VENTRICLE; HUMAN; MALE; REFERENCE VALUE; SURGICAL TECHNIQUE; THROMBOSIS; BLOOD; CONGENITAL MALFORMATION; HEART VENTRICLE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANTIGENS; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; FONTAN PROCEDURE; HEART VENTRICLES; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN;

EID: 18244392454     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951105000065     Document Type: Article

References (26)

1. Forbes TJ, Rosenthal GL, Reul Jr GR, Ott DA, Feltes TF. Risk factors for life-threatening cavopulmonary thrombosis in patients undergoing bidirectional superior cavopulmonary shunt: an exploratory study. Am Heart J 1997; 134: 865-871.
2. Hanséus K, Björkhem G, Jögi P, Sonesson S. Formation of thrombus and thromboembolism after the bidirectional Glenn anastomosis, total cavopulmonary connection and the Fontan operation. Cardiol Young 1998; 8: 211-216.
3. Day RW, Boyer RS, Tait VF, Ruttenberg HD. Factors associated with stroke following the Fontan procedure. Pediatr Cardiol 1995; 16: 270-275.
4. du Plessis AJ, Chang AC, Wessel DL, et al. Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 1995; 12: 230-236.
5. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997; 113: 989-992.
6. Rosenthal DN, Friedman AH, Kleinman CS, et al. Thromboembolic complications after Fontan operations. Circulation 1995; 92: II287-II293.
7. Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, et al. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990; 336: 1087-1090.
8. Jahangiri M, Kreutzer J, Zurakowski D, Bacha E, Jonas RA. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 2000; 120: 778-782.
9. Monagle P, Andrew M. Coagulation abnormalities after Fontan procedures. J Thorac Cardiovasc Surg 1998; 115: 732-733.
10. Odegard KC, McGowan Jr FX, DiNardo JA, et al. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 2002; 123: 459-465.
11. Odegard KC, McGowan Jr FX, Zurakowski D, et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 2002; 73: 1770-1777.
12. Rauch R, Ries M, Hofbeck M, et al. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 2000; 83: 678-682.
13. Ravn HB, Hjortdal VE, Stenbog EV, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001; 85: 61-65.
14. Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002; 8: 242-250.
15. Caramurú LH, Maeda NY, Lopes AA, Bydlowski SP. Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension. Clin Appl Thrombosis/Hemostasis 2004; 10: 217-223.
16. Wu KK, Matijevic-Aleksic N. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis. Ann Med 2000; 32: I73-I77.
17. Shreeniwas R, Ogawa S, Cozzolino F, et al. Macrovascular and microvascular endothelium during long-term hypoxia: alterations in cell growth, monolayer permeability, and cell surface coagulant properties. J Cell Physiol 1991; 146: 8-17.
18. Ogawa S, Gerlach H, Esposito C, et al. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 1990; 85: 1090-1098.
19. Goerge T, Niemeyer A, Rogge P, et al. Secretion pores in human endothelial cells during acute hypoxia. J Membrane Biol 2002; 187: 203-211.
20. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996; 97: 493-500.
21. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244-248.
22. Olli R, Celermajer DS. Testing for endothelial dysfunction. Ann Med 2000; 32: 293-304.
23. Mavromatis BH, Kessler CM. D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism. J Clin Pathol 2001; 54: 664-668.
24. Morgan VL, Graham Jr TP, Roselli RJ, Lorenz CH. Alterations in pulmonary artery flow patterns and shear stress determined with three-dimensional phase-contrast magnetic resonance imaging in Fontan patients. J Thorac Cardiovasc Surg 1998; 116: 294-304.
25. Khambadkone S, Li J, de Leval MR, et al. Basal pulmonary vascular resistence and nitric oxide responsiveness late after Fontan-type operation. Circulation 2003; 107: 3204-3208.
26. Mahle WT, Todd K, Fyfe DA. Endothelial function following the Fontan operation. Am J Cardiol 2003; 91: 1286-1288.